Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 110,863 | 64,039 | 38,380 | 83,190 |
| TOTAL | $114,095 | $66,383 | $40,013 | $84,409 |
| Non-Current Assets | ||||
| PPE Net | 2,339 | 3,858 | 4,797 | 5,648 |
| Investments And Advances | 0 | 0 | 748 | 376 |
| Other Non-Current Assets | 1,374 | 8,066 | 9,388 | 12,116 |
| TOTAL | $3,713 | $11,924 | $14,933 | $18,140 |
| Total Assets | $117,808 | $78,307 | $54,946 | $102,549 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 182 | 1,210 | 1,042 | 2,151 |
| Accrued Expenses | 5,632 | 4,833 | 3,302 | 3,425 |
| Other current liabilities | N/A | N/A | 405 | N/A |
| TOTAL | $15,514 | $9,598 | $7,807 | $7,946 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 9,387 | 385 | N/A | N/A |
| Other Non-Current Liabilities | 46,477 | 5,565 | 8,574 | 9,882 |
| TOTAL | $54,590 | $5,565 | $8,722 | $10,027 |
| Total Liabilities | $70,104 | $15,163 | $16,529 | $17,973 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 51,919 | 20,161 | N/A | N/A |
| Common Shares | 6 | 2 | 1 | 1 |
| Retained earnings | -292,156 | -211,753 | -159,962 | -110,671 |
| TOTAL | $47,704 | $63,144 | $38,417 | $84,616 |
| Total Liabilities And Equity | $117,808 | $78,307 | $54,946 | $102,589 |